Health Highlights: July 14, 2022
No rise in methadone ODs in pandemic, supporting use as at-home treatment. COVID crisis forced many opioid treatment centers to close, but addicts safely took the treatment at home, a new study finds. Read more
FDA approves Novavax as 4th COVID-19 vaccine. The two-dose vaccine employs nanoparticle technology to trigger an immune response, so it might be seen as alternative to mRNA-based shots from Pfizer or Moderna, experts say. Read more
Pharmacies must fill prescriptions for abortion meds, feds say. Failing to do so risks violating federal civil rights law barring sex discrimination, the Biden administration said on Wednesday. Read more
Demand is overwhelming NYC's effort to roll out monkeypox vaccine. The appointment system aimed at streamlining access to the vaccine crashed in America's largest city, one of many places where supplies have been running out almost as soon as they arrive. Read more
Cancer drug might be powerful treatment against multiple sclerosis. The drug, rituximab, is already used "off-label" for MS and is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. Read more
Asthma drug fails as potential COVID treatment. Despite hopes that the medicine might help, researchers found "no evidence" that fluticasone kept folks with mild-to-moderate COVID out of the hospital. Read more
Was this page helpful?
Related Posts
White House Press Secretary Jen Psaki Has COVID-19
MONDAY, Nov. 1, 2021 (HealthDay News) -- White House press secretary Jen Psaki...
In States Where Recreational Marijuana Legalized, Less Demand for Prescription Codeine
MONDAY, Jan. 23, 2023 (HealthDay News) -- New research suggests that there's one...
¿Se siente estresado por las noticias sobre Ucrania? Los expertos ofrecen consejos para sobrellevarlo
MIÉRCOLES, 9 de marzo de 2022 (HealthDay News) -- Las noticias y las imágenes...
It’s Snow Season: Stay Safe on the Slopes
SUNDAY, Dec. 11, 2022 (HealthDay News) -- Skiiers and snowboarders, take note:...